XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 15,216 $ 17,083 $ 29,273 $ 32,831
Selling, general and administrative 19,532 19,758 40,267 38,928
Total operating expenses 34,748 36,841 69,540 71,759
Loss from operations (6,835) (14,401) (16,683) (30,848)
Non-operating expense, net:        
Foreign exchange (loss) gain (104) 118 (302) (278)
Interest expense (1,348) (1,338) (2,728) (2,310)
Other (expense) income, net (30) 337 (812) 793
Total non-operating expense, net (1,482) (883) (3,842) (1,795)
Loss before income taxes (8,317) (15,284) (20,525) (32,643)
Provision for income taxes 78 77 154 175
Net loss (8,395) (15,361) (20,679) (32,818)
Net loss attributable to noncontrolling interest (6)   (6)  
Net loss attributable to Cerus Corporation $ (8,389) $ (15,361) $ (20,673) $ (32,818)
Net loss per share attributable to Cerus Corporation        
Basic and diluted $ (0.05) $ (0.09) $ (0.12) $ (0.19)
Weighted average shares outstanding:        
Basic and diluted 176,944 171,240 175,718 170,039
Product        
Revenue $ 40,999 $ 31,484 $ 78,443 $ 54,863
Cost of revenue 19,718 15,323 37,794 26,418
Gross profit 21,281 16,161 40,649 28,445
Government Contract        
Revenue $ 6,632 $ 6,279 $ 12,208 $ 12,466